PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells

References

• JankuFStewartDJKurzrockRTargeted therapy in non-small-cell lung cancer – is it becoming a reality?Nat Rev Clin Oncol20107740141420551945
   PubMed Web of Science ®Google Scholar
• ScagliottiGVPotential role of multi-targeted tyrosine kinase inhibitors in non-small-cell lung cancerAnn Oncol200718Suppl 103241
   Web of Science ®Google Scholar
• DarnellJEJrStats and gene regulationScience19972775332163016359287210
   PubMed Web of Science ®Google Scholar
• JingNTweardyDJTargeting Stat3 in cancer therapyAnticancer Drugs200516660160715930886
   PubMed Web of Science ®Google Scholar
• GritskoTWilliamsATurksonJPersistent activation of Stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cellsClin Cancer Res2006121111916397018
   PubMed Web of Science ®Google Scholar
• SongLTurksonJKarrasJGJoveRHauraEBActivation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cellsOncogene200322274150416512833138
   PubMed Web of Science ®Google Scholar
• IkutaKTakemuraKKiharaMOverexpression of constitutive signal transducer and activator of transcription 3 mRNA in cisplatin-resistant human non-small cell lung cancer cellsOncol Rep200513221722215643501
   PubMed Web of Science ®Google Scholar
• KawakamiSHashidaMTargeted delivery systems of small interfering RNA by systemic administrationDrug Metab Pharmacokinet200722314215117603214
   PubMed Web of Science ®Google Scholar
• PutralLNGuWMcMillanNARNA interference for the treatment of cancerDrug News Perspect200619631732416971967
   PubMed Web of Science ®Google Scholar
• WangYGaoSYeWHYoonHSYangYYCo-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymerNat Mater200651079179616998471
   PubMed Web of Science ®Google Scholar
• DevalapallyHDuanZSeidenMVAmijiMMModulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticlesClin Cancer Res200814103193320318483388
   PubMed Web of Science ®Google Scholar
• JainRAThe manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide acid) (PLGA) devicesBiomaterials200021232475249011055295
   PubMed Web of Science ®Google Scholar
• PanyamJLabhasetwarVBiodegradable nanoparticles for drug and gene delivery to cells and tissueAdv Drug Deliv Rev200355332934712628320
   PubMed Web of Science ®Google Scholar
• PanyamJLabhasetwarVSustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticlesMol Pharm200411778415832503
   PubMed Web of Science ®Google Scholar
• BilatiUAllemannEDoelkerEDevelopment of a nanoprecipittion method intended for the entrapment of hydrophilic drugs into nanoparticlesEur J Pharm Sci2005241677515626579
   PubMed Web of Science ®Google Scholar
• CuiWBeiJWangSPreparation and evaluation of poly(L-lactide-co-glycolide) (PLGA) microbubbles as a contrast agent for myocardial contrast echocardiographyJ Biomed Mater Res B Appl Biomater200573117117815678494
   PubMed Web of Science ®Google Scholar
• ChengFYWangPHSuCHStabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probesBiomaterials200829132104211218276001
   PubMed Web of Science ®Google Scholar
• ChengFYSuCHWuPCYehCSMultifunctional polymeric nanoparticles for combined chemotherapeutic and near-infrared photothermal cancer therapy in vitro and in vivoChem Commun (Camb)201046183167316920424762
   PubMed Web of Science ®Google Scholar
• YuanXNaguibSWuZRecent advances of siRNA delivery by nanoparticlesExpert Opin Drug Deliv20118452153621413903
   PubMed Web of Science ®Google Scholar
• YezhelyevMVQiLO’ReganRMNieSGaoXProton-sponge coated quantum dots for siRNA delivery and intracellular imagingJ Am Chem Soc2008130289006901218570415
   PubMed Web of Science ®Google Scholar
• MartelloLAVerdier-PinardPShenHJElevated levels of microtubule destabilizing factors in a Taxol-resistant/dependent A549 cell line with an alpha-tubulin mutationCancer Res20036361207121312649178
   PubMed Web of Science ®Google Scholar
• HsiehCCKuoYHKuoCCChamaecypanone C, a novel skeleton microtubule inhibitor, with anticancer activity by trigger caspase 8-Fas/FasL dependent apoptotic pathway in human cancer cellsBiochem Pharmacol20107991261127120034474
   PubMed Web of Science ®Google Scholar
• MengHLiongMXiaTEngineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell lineACS Nano2010484539455020731437
   PubMed Web of Science ®Google Scholar
• DongYFengSSIn vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapyBiomaterials200728284154416017576004
   PubMed Web of Science ®Google Scholar
• ZhangXLiYChenXSynthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugateBiomaterials200526142121212815576187
   PubMed Web of Science ®Google Scholar
• GaucherGMarchessaultRHLerouxJCPolyester-based micelles and nanoparticles for the parenteral delivery of taxanesJ Control Release2010143121219925835
   PubMed Web of Science ®Google Scholar
• KimYHParkJHLeeMKimYHParkTGKimSWPolyethylenimine with acid-labile linkages as a biodegradable gene carrierJ Control Release2005103120921915710512
   PubMed Web of Science ®Google Scholar
• GwakSJKimBSPoly(lactic-co-glycolic acid) nanosphere as a vehicle for gene delivery to human cord blood-derived mesenchymal stem cells: comparison with polyethylenimineBiotechnol Lett20083071177118218317698
   PubMed Web of Science ®Google Scholar
• PatilYPanyamJPolymeric nanoparticles for siRNA delivery and gene silencingInt J Pharm20093671–219520318940242
   PubMed Web of Science ®Google Scholar
• SahayGAlakhovaDYKabanovAVEndocytosis of nanomedicinesJ Control Release2010145318219520226220
   PubMed Web of Science ®Google Scholar
• DongXMattinglyCATsengMTDoxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATPCancer Res20096993918392619383919
   PubMed Web of Science ®Google Scholar
• MayurYCPetersGJPrasadVVLemoCSathishNKDesign of new drug molecules to be used in reversing multidrug resistance in cancer cellsCurr Cancer Drug Targets20099329830619442050
   PubMed Web of Science ®Google Scholar
• HuCMZhangLTherapeutic nanoparticles to combat cancer drug resistanceCurr Drug Metab200910883684120214578
   PubMed Web of Science ®Google Scholar
• CartieraMSJohnsonKMRajendranVCaplanMJSaltzmanWMThe uptake and intracellular fate of PLGA nanoparticles in epithelial cellsBiomaterials200930142790279819232712
   PubMed Web of Science ®Google Scholar
• NgDCLinBHLimCPStat3 regulates microtubules by antagonizing the depolymerization activity of stathminJ Cell Biol2006172224525716401721
   PubMed Web of Science ®Google Scholar
• DavisMEChenZGShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
   PubMed Web of Science ®Google Scholar
• AzarmiSRoaWHLobenbergRTargeted delivery of nanoparticles for the treatment of lung diseasesAdv Drug Deliv Rev200860886387518308418
   PubMed Web of Science ®Google Scholar
• PatilYBSwaminathanSKSadhukhaTMaLPanyamJThe use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistanceBiomaterials201031235836519800114
   PubMed Web of Science ®Google Scholar